Skip to main content
Irwin Naturals Inc. logo

Irwin Naturals Inc. — Investor Relations & Filings

Ticker · IWIN ISIN · CA46414Q1054 LEI · 9845003CF0B7JE8FAX54 CSE Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2023-03-24 Interim / Quarterly Rep…
Country CA Canada
Listing CSE IWIN

About Irwin Naturals Inc.

https://irwinnaturals.com/

Irwin Naturals Inc. is a nutraceutical company focused on developing and distributing premium health supplements and vitamins. The company specializes in soft-gel based herbal formulas, prioritizing superior potency, bioavailability, and absorption. Its product portfolio includes targeted formulas for general wellness, sleep, cognitive function, detoxification, and weight management, alongside a range of CBD and THC products. A core unique selling proposition is the utilization of an all-liquid soft-gel delivery system combined with the signature BioPerine Complex, which is designed to enhance nutrient uptake. Irwin Naturals distributes its extensive line of supplements through mass-market and health food chain retailers across North America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) for the three-month and six-month periods ended January 31, 2023. It includes detailed narrative explanations of the company's financial condition, operations, exploration activities, and business development highlights for these interim periods. The document references compliance with Canadian Securities Administrators rules for continuous disclosure and complements condensed interim financial statements. It contains substantive financial data and analysis for a period shorter than a full fiscal year (quarter and half-year). Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q2 2023
2023-03-24 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing the acquisition of Ketamine Media by Irwin Naturals. It discusses the strategic rationale, expected benefits, and regulatory overview related to ketamine therapy. There are no financial statements, detailed financial performance data, or comprehensive management analysis. The document is not a full annual or interim report, nor is it a regulatory filing or certification. It is an announcement of a corporate transaction (acquisition) and related business update. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2023-03-22 English
News release - English.pdf
Regulatory Filings
2023-03-16 English
Material change report (amended) - English.pdf
Regulatory Filings
2023-02-22 English
News release - English.pdf
Call Transcript Classification · 85% confidence The document is a press release announcing an upcoming conference call to discuss the fourth quarter and full year 2022 financial results of Zymeworks Inc. It provides details about the date and time of the call and webcast information but does not contain any actual financial data or detailed financial results. The document length is short (3002 characters), and it primarily serves as an announcement for the event rather than the report or transcript itself. Therefore, it fits the category of a Call Transcript announcement or conference call notice. However, since it is only announcing the call and not the transcript, the best fitting category is Call Transcript (CT) as it relates to the conference call event.
2023-02-21 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 51-102F3 MATERIAL CHANGE REPORT' and details a material change involving an asset purchase agreement and issuance of shares as consideration. It includes dates of material change, summary, full description, and officer contact information. The form number and content indicate it is a regulatory filing reporting a material change event, not a full financial report or earnings release. The document length is 4718 characters, which is relatively short and focused on a specific event. There is no detailed financial data or comprehensive analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a proxy, AGM material, or management discussion. The content fits the category of Regulatory Filings (RNS) as a material change report under securities regulations, reporting a significant corporate event without being a full report itself.
2023-02-07 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.